This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/cti-biopharma-stock-price-acquisition-sobi-f18cf3af

CTI BioPharma Stock Soars After Agreeing to $1.7 Billion Sale. Biotech Deals Keep Coming.

By
Adam Clark
  • Order Reprints
  • Print Article

Shares in CTI BioPharma leapt on Wednesday after the U.S. biotechnology company agreed to be acquired.  

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.